Gene Query: SLC39A7

Dataset Description Geneva Score
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 56.05
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 56.05
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 44.24
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 34.85
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 33.78
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 27.11
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 26.09
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 26.03
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 25.67
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 25.66
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 21.41
Mitochondrial dsRNA triggers antiviral signalling in humans 21.34
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 19.54
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 18.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 17.7
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 17.7
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 17.05
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 16.63
Differentially expressed genes post knock down of lincDUSP26 16.52
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 16.52
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 16.39
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 15.83
Modeling Familial Cancer with iPSC Approaches 15.72
Uridylation by TUT4 and TUT7 marks mRNA for degradation 15.7
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 15.43
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 15.17
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 14.81
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 14.54
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 14.26
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 14.12
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 14.08
Gene expression in PANC1 cells treated with Rakicidin 13.98
Expression by CD133+ cells isolated from the adult human exocrine pancreas 13.85
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 13.63
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 13.46
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.17
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 13.14
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 13.14
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 13.03
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 13.01
Transcriptomic analysis of the HOTAIR-regulated genes 12.94
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 12.84
The human blood-nerve barrier transcriptome 12.53
TGF-β regulation of miRNA expression in pancreatic cancer 12.53
Microprocessor mediates transcription termination in long noncoding microRNA genes 12.4
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.4
Lipid degradation promotes prostate cancer cell survival 12.33
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 12.31
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 12.26
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 12.12
Morphological and molecular characterization of human dermal lymphatic collectors 12.06
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.04
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.04
Gene expression changes caused by KRAS in MCF-10A 12.04
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 12.0
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.97
Differetially expressed genes after hTR overexpression in U2OS cells 11.95
Sensing self and nonself circular RNAs 11.95
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.85
The interplay between SOX4 and SMAD3 in the context of breast cancer 11.75
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 11.68
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.66
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.66
Reassessment of Exosome Composition 11.63
Tracking of dCas9-methyltransferase footprints 11.54
Identifying the molecular mode of action of itraconazole in colorectal cancer 11.4
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 11.24
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 11.24
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 11.18
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.16
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.98
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.98
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.91
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 10.85
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 10.76
T47D RNA-seq and ChrRNA-seq data 10.76
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 10.74
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 10.71
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 10.71
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.66
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.66
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.56
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 10.52
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 10.48
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.4
3’ Uridylation Expands miRNA Target Repertoire 10.29
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 10.27
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 10.19
TCF7L1 knockdown in pancreatic cancer 10.09
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.06
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 10.04
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 10.01
The pause-initiation limit restricts transcription activation in human cells 10.0
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.0
RNA-sequencing of formalin fixed human primary melanoma tissue 9.98
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 9.96
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 9.87
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 9.86
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.83
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.75
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.75
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.71
Gene expression profiling of human and murine in vitro muscle differentiation 9.65
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.63
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 9.58
Expression profiling of MCF-7 cells with treatment of TCDD 9.58
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 9.58
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 9.54
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.44
RNA-seq melanoma 9.36
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.31
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.31
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.29
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 9.21
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 9.19
Genome-wide analysis of Dengue virus 2 infected cells 9.19
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.15
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 9.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 9.13
Be1 and Be2 B cells are transcriptionally distinct 9.12
miR941 overexpression experiment 9.11
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 9.07
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 9.05
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 9.03
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 8.93
Genome wide expression change by RNF168 knocking down in MCF-7 cells 8.91
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.87
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 8.84
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 8.84
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 8.82
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 8.82
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.8
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 8.79
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 8.78
CD73 knockdown effect in pancreatic cancer cell lines 8.77
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.75
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 8.74
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 8.61
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.56
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.56
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 8.5
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 8.49
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 8.49
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 8.49
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 8.49
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 8.47
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.46
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 8.41
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  8.39
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 8.35
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.35
The evolution of N6-methyladenosine in primates 8.34
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 8.33
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.32
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 8.32
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 8.32
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 8.27
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 8.24
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.23
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 8.22
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 8.22
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.1
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.97
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.97
circRNA profile in hypopharyngeal cancer 7.92
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.9
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.83
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 7.82
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 7.82
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 7.8
RNA transcriptome analysis during HSV-1 infection 7.8
Identification of a LIF-responsive replication-competent human β cell 7.79
Cajal bodies are linked to genome conformation [RNA-Seq] 7.76
Cajal bodies are linked to genome conformation 7.76
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.68
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 7.66
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.64
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 7.64
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 7.63
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 7.63
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.57
Hepatitis C virus functionally sequesters miR-122 7.57
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 7.55
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.54
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 7.54
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 7.52
TT-Seq captures the human transient transcriptome 7.5
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 7.44
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.42
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 7.37
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.37
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 7.36
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 7.36
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 7.35
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.31
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.31
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.29
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.29
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 7.27
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.24
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.24
U1 snRNP telescripting regulates size-function stratified human genome 7.18
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 7.18
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 7.16
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.16
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 7.13
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 7.1
High-throughput sequencing of pluripotent cells 7.05
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.04
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.01
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.01
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.0
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.0
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.91
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.9
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 6.89
Regulation of highly expressed hCINAP on translatome 6.87
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.82
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.79
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.79
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 6.77
scRNASeq analysis of cycling cardiomyocytes 6.77
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.75
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.7
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.7
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 6.64
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 6.64
AR-independent prostate cancer is sustained through FGF signaling 6.57
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.56
The conserved transcriptional landscapes in human spermatogenesis 6.55
Gene expression profile of human placenta from T. Cruzi infected mothers 6.53
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.5
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 6.45
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 6.43
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.43
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.41
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.38
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.38
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 6.33
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 6.33
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 6.32
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 6.3
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 6.26
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.25
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 6.23
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.21
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.2
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.2
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.2
Identification of HOXB13 target genes responsive to BET inhibitors 6.15
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.05
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.05
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.02
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.02
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 6.02
RNA-seq of IL-4 stimulated human keratinocytes 5.97
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.9
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 5.88
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.87
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.86
Positively selected enhancer elements endow tumor cells with metastatic competence 5.83
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 5.82
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 5.78
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 5.78
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.75
Evaluating pre-clinical models for studying NASH driven HCC. 5.7
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.67
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.65
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.57
Regulation of poly(A) tail and translation during the somatic cell cycle 5.54
Systematic discovery of endogenous human ribonucleoprotein complexes 5.48
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.47
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 5.41
Exploring the RNA landscape of endothelial exosomes 5.4
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 5.39
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.36
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.32
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 5.22
NAPRT activation of macrophages 5.13
The MEF2B Regulatory Network 5.12
The MEF2B Regulatory Network - RNA-seq data 5.12
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.1
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 5.08
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.07
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.07
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.07
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 5.06
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 5.0
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 4.95
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.9
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 4.77
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.71
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.63
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 4.62
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.52
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.51
DRB/GRO-Seq -/+ UV 4.51
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.49
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.46
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.44
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.41
Profiling of escape kinetics of viruses subjected to RNAi 4.4
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 4.4
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.35
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.29
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.27
RNA-seq of RKO cells with cTAZ KO or putback 4.27
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.17
Genome-wide analysis of the Integrator complex (HTS) 4.16
Genome-wide analysis of the Integrator complex 4.16
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.16
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.09
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.08
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.08
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.07
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.05
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.05
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.01
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.96
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.92
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.91
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 3.87
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 3.87
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 3.85
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.85
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.84
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.84
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.83
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.81
RNA editing in nascent RNA affects pre-mRNA splicing 3.75
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.75
Argonaute proteins couple chromatin silencing to alternative splicing 3.75
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.73
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.66
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.66
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.65
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.65
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.64
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.62
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.57
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.55
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.51
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.48
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.47
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.47
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.46
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.43
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.43
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.39
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.37
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.37
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 3.37
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.3
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.3
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 3.3
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.24
Measure transcript integrity using RNA-seq data 3.18
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.08
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.07
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.07
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.06
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.05
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 3.05
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.03
Activity-dependent transcriptional changes in human neurons 2.97
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.94
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.93
Transcriptome analysis upon C6orf203 silencing 2.9
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.89
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.81
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.72
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.67
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.67
Genome-wide discovery of human splicing branchpoints 2.66
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.62
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.57
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.57
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.56
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 2.48
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.45
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.4
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.4
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.37
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 2.36
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.36
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.35
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.31
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.29
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.29
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.29
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.23
Transcriptomes of human monocytes after ex vivo exposure to uric acid 2.1
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.09
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.04
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.96
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.95
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.91
BET bromodomain inhibition 1.91
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.89
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.84
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.82
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.74
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.73
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.71
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.69
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.64
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.59
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.58
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.55
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.54
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.52
RNA Sequencing of Human iPS derived Cardiomyocytes 1.51
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.49
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.46
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.44
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.38
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.38
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.25
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.22
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.22
siRNA-mediated knockdown 1.21
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.2
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.18
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.18
Enhancer activation during EGF response 1.15
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.14
Induced DNA demethylation, genome instability and transcription 1.14
Ribosome profiling upon inhibition of eIF4A 1.12
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.1
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.1
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.09
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.08
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.08
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.03
Transposon-based construction of strand-specific RNA-seq libraries 1.03
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.95
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.94
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.94
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.94
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.93
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.93
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.92
Transcriptome-wide modulation of splicing by the exon junction complex 0.9
Global response to chemotherapy-induced apoptosis 0.88
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.87
Differential gene expression profiles in imatinib-resistant cell lines 0.81
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.78
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.76
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.72
KLF6-dependent transcription in renal cancer cells 0.72
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.7
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.7
The gene expression profiles of gallbladder cancer 0.68
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.66
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.65
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.65
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.63
Metabolism as an early predictor of DPSCs aging 0.62
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.62
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.6
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.56
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.56
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.52
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.5
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.5
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.5
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.5
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.49
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.46
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.45
Gene expression profiling of KSHV-infected periodontal ligament cells 0.39
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.38
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.38
Determining mRNA half-lives on a transcriptome-wide scale 0.37
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.33
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.33
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.32
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.27
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.25
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.24
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.2
Gene expression analysis of human adenomas. 0.18
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.16
MHC Transcriptomic landscape at haplotype-specific resolution 0.11
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.1
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.09
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.08
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.06
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.05
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.04
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.04
6mer seed toxicity in viral microRNAs 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.01
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation